
About Priska Pharma
Priska Pharma is a Healthcare company. Online provider of nutritional supplements and medicines for pregnant and lactating women in India. Its Indian entity Priska Pharma Private Limited reported revenue of ₹2.09 Cr. Priska Pharma offers products and services including FOLIPREG® and Myramax® MOM. Its focus areas include E-commerce, Online Pharmacy, Health Retail Services and Pharmaceuticals.
Company details
Priska Pharma is identified as a provider of nutritional supplements and medicines that are directed towards pregnant and lactating women, with an online platform where products like FOLIPREG and Myramax are listed for purchase. Addresses in New Delhi, NOIDA, and PATNA are noted, along with services such as secure payments and fast shipping under specified terms. Customer support is made available through email and phone during designated hours, ensuring assistance is extended without promotional emphasis. The companys operations are observed to focus on maternal health, with policies on privacy and refunds being outlined for transparency.
- SectorsHealthcare
- Website priskapharma.com
- Legal Name Priska Pharma Pvt. Ltd
- Date of Incorporation 04 Feb, 2015
- Jurisdiction New Delhi, Delhi, India
- Indian entity revenue₹2.09 Cr
FY 2025 · +36% YoY
- Indian entity net profit₹76.7 Lakh
FY 2025 · 37% margin
- Indian entity EBITDA₹1.07 Cr
FY 2025 · 51% margin
Associated legal entities of Priska Pharma
Priska Pharma operates through Priska Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Priska Pharma Private Limited CIN U24100DL2015PTC276308 | Active | 04 Feb 2015 | New Delhi, Delhi | ₹2.1 Cr | 5 | View details |
Products & Services of Priska Pharma
Priska Pharma offers a comprehensive portfolio of products and services, including FOLIPREG® and Myramax® MOM.
Nutritional supplements for pregnant women are provided to support health needs.
Powder-based medicines for lactating women are offered in various flavors to aid wellness.
Board of directors of Priska Pharma Private Limited (Priska Pharma)
Priska Pharma Private Limited is the primary company behind Priska Pharma. The board of Priska Pharma Private Limited currently have 5 directors; the longest-serving is Amod Kumar, appointed in 2023. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Amod Kumar DIN 09815430 | Director | 21 Jan 2023 | 3 yrs 9 mo | Priska Pharma Private Limited |
| Vikash Pandey DIN 09815272 | Director | 21 Jan 2023 | 3 yrs 9 mo | Priska Pharma Private Limited |
| Kundan Kumar DIN 10748825 | Additional Director | 31 Aug 2024 | 2 yrs 2 mo | Priska Pharma Private Limited |
| Ajeet Kumar DIN 10748826 | Additional Director | 31 Aug 2024 | 2 yrs 2 mo | Priska Pharma Private Limited |
| Manas Kumar Sircar DIN 11049600 | Additional Director | 25 Apr 2025 | 1 yr 6 mo | Priska Pharma Private Limited |
Financials of Priska Pharma
Figures of Priska Pharma Private Limited, the primary company behind Priska Pharma, for FY 2025. Revenue was ₹2.09 Cr (+36% year on year). Net profit was ₹76.7 Lakh (37% margin). EBITDA was ₹1.07 Cr (51% margin). Revenue has grown at a compounded annual rate of +13% over three years and +10% over five years.
- ₹2.09 CrRevenue · FY 2025 · +36% YoY
- ₹76.7 LakhNet profit · 37% margin
- ₹1.07 CrEBITDA · 51% margin
- ₹10 LakhPaid-up capital
- +13%Revenue CAGR, 3 years
- +10%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Priska Pharma Private Limited are on its company page.
Detailed financial statements for Priska Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Priska Pharma
The primary company behind Priska Pharma, Priska Pharma Private Limited, reported revenue of ₹2.09 Cr for FY 2025, up 36% year on year.
Priska Pharma is identified as a provider of nutritional supplements and medicines that are directed towards pregnant and lactating women, with an online platform where products like FOLIPREG and Myramax are listed for purchase. Addresses in New Delhi, NOIDA, and PATNA are noted, along with services such as secure payments and fast shipping under specified terms. Customer support is made available through email and phone during designated hours, ensuring assistance is extended without promotional emphasis. The companys operations are observed to focus on maternal health, with policies on privacy and refunds being outlined for transparency.
Priska Pharma offers FOLIPREG® and Myramax® MOM.
Priska Pharma operates through Priska Pharma Private Limited.
The legal entities of Priska Pharma currently have 5 directors, including Amod Kumar, Vikash Pandey, Kundan Kumar and others.